Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
The 2023-2028 World Outlook for Clinical Trials
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Clinical Trial Management
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Clinical Trial Management Systems
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Clinical Trial Consumables
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for ePRO, E-Patient Diaries and eCOA
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
Global Clinical Trials Matching Software Market Size study, by Deployment Type (Web & Cloud Based, On-premise), End Use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), and Regional Forecasts 2022-2028
... Market is valued at approximately USD 132.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.07% over the forecast period 2022-2028. Clinical trial matching software help patients ... Read More
-
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
... Nearly 350 million people will quit smoking across the 16 countries covered in GlobalData’s epidemiology forecast for smoking cessation. There are two leading marketed drugs for the treatment of smoking cessation. R&D activity in smoking ... Read More
-
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
... In 2022, there will be more than 1,490,000 diagnosed prevalent cases of renal cell carcinoma across 16 pharmaceutical markets. There are 10 leading marketed drugs for the treatment of renal cell carcinoma, Merck is a ... Read More
-
Pharmacovigilance Market, By Type of Clinical Trial Phases (Pre-clinical Studies, Clinical Trial Phase I, Clinical Trial Phase II, Clinical Trial Phase III, Post Marketing Surveillance or Phase IV), By Type of Method (Spontaneous Reporting, Intensified AD
... ADR Reporting, Targeted Reporting, Cohort Event Monitoring, EHR Monitoring), By Type of Service Providers (In-House, Contract Outsourcing), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and ... Read More
-
Growth Opportunities for Digital Twins in Global Healthcare
... decision-making. DT technology initially saw application in the production and engineering fields with Industry 4.0, but it has advanced and become revolutionary in the healthcare industry. In healthcare, developers can create a DT for a ... Read More
-
Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Interventional (Randomized Trial, Non-randomized Trial, and Crossover Trial), and Observational), by Medical Condition (Neuropsych
... Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases, Diabetes, Nutritional Deficiencies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, ... Read More
-
Anorexia - Market Insight, Epidemiology And Market Forecast - 2032
... anorexia nervosa market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The anorexia nervosa market report provides current treatment practices, emerging drugs, market share of the individual ... Read More
-
Acute Respiratory Distress Syndrome (ARDS) - Epidemiology Forecast - 2032
... the Acute Respiratory Distress Syndrome trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. Acute Respiratory Distress Syndrome Disease Understanding Acute respiratory distress syndrome (ARDS) is a severe ... Read More
-
Global Clinical Trial Management System Market Size study, By Deployment (Enterprise-wide CTMS, On-Site CTMS), By Delivery (Web-based {On-demand}), Licensed Enterprise {On-premises}), Cloud-based {SaaS}), By Product & Service (Software, Services), By End-User (Large Pharma-biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-sized Pharma-biotech Companies, Other End-Users), and Regional Forecasts 2022-2028
... Medical Device Manufacturers, Small & Mid-sized Pharma-biotech Companies, Other End-Users), and Regional Forecasts 2022-2028 Global Clinical Trial Management System Market is valued at approximately USD 801 million (0.801 billion) in 2021 and is anticipated to ... Read More
-
Global Clinical Trial Supplies Market Size study, by Service (Logistics & distribution, Storage & retention, Packaging, labeling, and blinding, Manufacturing, Comparator sourcing, Other services), by End-Use (Pharmaceutical & Biotechnology companies, Contract Research Organisations (CROs), Medical Devices Companies) and Regional Forecasts 2022-2028
... Devices Companies) and Regional Forecasts 2022-2028 Global Clinical Trial Supplies Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % ... Read More
-
Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Anal Cancer (Oncology) pipeline landscape. Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of ... Read More
-
B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline landscape. B-Cell Chronic Lymphocytic Leukemia is a type of slow growing leukemia that affects developing B-lymphocytes (also known as B-cells). ... Read More
-
Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... the cytoskeleton via F-actin. It acts as ligand for dystroglycan. It acts as component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction and at a variety of synapses in the peripheral and ... Read More
-
Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Oral Mucositis (Gastrointestinal) pipeline landscape. Oral mucositis is the most common type of mucositis. It is a debilitating complication of cancer surgery, chemotherapy and radiation. Symptoms include change in color, ... Read More
-
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... pipeline Target constitutes close to 48 molecules. Out of which approximately 37 molecules are developed by companies and remaining by the universities/institutes. The latest report Bromodomain Containing Protein 4 - Drugs In Development, 2022, outlays ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Alpha-1 Antitrypsin Deficiency (A1AD) (Genetic Disorders) pipeline landscape. Alpha-antitrypsin deficiency is an inherited disease that occurs due to lack of alpha-1 antitrypsin (AAT), a protein that ... Read More
-
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Bone Marrow Transplant Rejection (Immunology) pipeline landscape. Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The ... Read More
-
Acute Myeloid Leukemia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... therapeutics. Synopsis In 2022, there will be more than 156,000 diagnosed prevalent cases of acute myeloid leukemia across 16 pharmaceutical markets. There are 10 leading marketed drugs for the treatment of acute myeloid leukemia, Bristol ... Read More
-
Blepharitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Blepharitis (Ophthalmology) pipeline landscape. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, ... Read More
-
Juvenile Macular Degeneration (Stargardt Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Juvenile Macular Degeneration (Ophthalmology) pipeline landscape. Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults. The most common form ... Read More
Research Assistance
